Lewis, Mitra
Glucagon Receptor Activation The glucagon receptor activation distinguishes Retatrutide from all other approved or developmental obesity medications
PubMed 42.Levey AS, Bosch JP, Lewis JB, et al
Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, OFarrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
Additionally, it slows gastric emptying, the process by which food leaves the stomach and enters the small intestine